Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Immunome Inc (IMNM)

Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Thu Feb 5, 3:00PM CST

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on February 2, 2026, the...

IMNM : 22.16 (-1.25%)
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Business Wire - Wed Feb 4, 7:00AM CST

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at Guggenheim's...

IMNM : 22.16 (-1.25%)
Record $2.5B Sector Start Spotlights Clinical Oncology Plays BayStreet.ca - Fri Jan 30, 8:44AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The global oncology market is surging toward $668.26 billion by 2034 with an 11.50% CAGR as innovative...

ALLO : 1.8000 (+11.11%)
ONCY : 1.0600 (+26.99%)
IMNM : 22.16 (-1.25%)
LLY : 1,040.00 (+0.33%)
KURA : 8.31 (+3.62%)
AMGN : 369.19 (+0.82%)
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Thu Jan 8, 3:05PM CST

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the...

IMNM : 22.16 (-1.25%)
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference Business Wire - Tue Jan 6, 7:00AM CST

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at...

IMNM : 22.16 (-1.25%)
Novel Modalities Drive $668B Precision Oncology Expansion BayStreet.ca - Fri Jan 2, 10:34AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The global oncology market is projected to reach US$668.26 billion by 2034[1], as investors increasingly...

ONCY : 1.0600 (+26.99%)
PSTV : 0.2752 (+7.08%)
IMNM : 22.16 (-1.25%)
BCYC : 5.24 (-2.24%)
CELC : 104.51 (-0.34%)
Immunome Announces Pricing of Public Offering of Common Stock Business Wire - Tue Dec 16, 2025

Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the pricing of an underwritten...

IMNM : 22.16 (-1.25%)
View 2 of the trading floor of New York Stock Exchange by Lev Radin via Shutterstock
Stocks Fall Ahead of US November Payroll Report Barchart - Mon Dec 15, 2025

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.51%....

MSTR : 133.88 (+8.85%)
IMNM : 22.16 (-1.25%)
GLXY : 21.66 (+7.49%)
BLDR : 114.73 (-4.84%)
$IUXX : 24,732.73 (+0.18%)
COIN : 164.32 (+16.46%)
ZNH26 : 113-055s (+0.33%)
OXY : 46.07 (+1.28%)
ESH26 : 6,850.50s (-0.01%)
FANG : 169.14 (+1.03%)
LYB : 57.61 (-0.29%)
$DOWI : 49,500.93 (+0.10%)
Immunome Announces Proposed Public Offering of Common Stock Business Wire - Mon Dec 15, 2025

Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten...

IMNM : 22.16 (-1.25%)
2d illustration of Cloud computing by Blackboard via Shutterstock
Stocks Turn Lower on AI Spending Concerns Barchart - Mon Dec 15, 2025

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.26%. December E-mini...

MSTR : 133.88 (+8.85%)
AMAT : 354.91 (+8.08%)
IMNM : 22.16 (-1.25%)
GLXY : 21.66 (+7.49%)
BLDR : 114.73 (-4.84%)
AKAM : 111.76 (+6.83%)
$IUXX : 24,732.73 (+0.18%)
COIN : 164.32 (+16.46%)
ZNH26 : 113-055s (+0.33%)
OXY : 46.07 (+1.28%)
ESH26 : 6,850.50s (-0.01%)
FANG : 169.14 (+1.03%)

Barchart Exclusives

Why Wedbush Thinks Norway Could Be Key for This Quantum Computing Stock -- and the Entire Industry Barchart - 1 minute ago
Norway's sovereign wealth fund invested $200 million in IonQ, $39 million in Rigetti, and $4 million in D-Wave. Wedbush sees this as a potential turning point for institutional investment in quantum computing stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot